Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTES OF HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary, Private

Established: 1948-01-01

Employees: 1K

Market Cap: -

Website: http://www.nidcr.nih.gov

Clinical Trials

Interaction of Cobalamin Status With Nitrous Oxide in Relation to Postoperative Cognitive Changes in the Elderly

Not Applicable

Completed

Conditions: Avitaminosis
Delirium, Dementia, Amnestic, Cognitive Disorders

Interventions: Drug: General anesthesia with nitrous oxide
Drug: General anesthesia without nitrous oxide

First Posted Date: 2005-09-21

Last Posted Date: 2022-08-08

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 444

Registration Number: NCT00212147

Locations: 🇺🇸
New York Methodist Hospital, Brooklyn, New York, United States
🇺🇸
WeillMedical College of Cornell University, New York, New York, United States

Intensity Modulated Radiation Therapy for Prostate Cancer

Early Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Radiation: Radiation

First Posted Date: 2005-09-21

Last Posted Date: 2019-07-19

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 19

Registration Number: NCT00214422

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase 2

Completed

Conditions: Extensive Stage Small Cell Lung Cancer
Recurrent Small Cell Lung Cancer

Interventions: Drug: sorafenib tosylate

First Posted Date: 2005-09-16

Last Posted Date: 2014-05-21

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 89

Registration Number: NCT00182689

Locations: 🇺🇸
SWOG, Portland, Oregon, United States

Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer

Phase 1

Completed

Conditions: Fallopian Tube Cancer
Female Reproductive Cancer
Stage III Ovarian Epithelial Cancer
Recurrent Ovarian Epithelial Cancer
Stage IV Breast Cancer
Recurrent Breast Cancer
Stage IV Ovarian Epithelial Cancer

Interventions: Drug: ixabepilone
Drug: pegylated liposomal doxorubicin hydrochloride

First Posted Date: 2005-09-16

Last Posted Date: 2016-03-10

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 45

Registration Number: NCT00182767

Locations: 🇺🇸
Women's Cancer Care Associates LLC, Albany, New York, United States
🇺🇸
Montefiore Medical Center - Moses Campus, Bronx, New York, United States
🇺🇸
University of Connecticut, Farmington, Connecticut, United States

and more 2 locations

Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Phase 2

Completed

Conditions: Stage IV Renal Cell Cancer
Clear Cell Renal Cell Carcinoma
Recurrent Renal Cell Cancer
Stage III Renal Cell Cancer

Interventions: Drug: ixabepilone
Other: laboratory biomarker analysis

First Posted Date: 2005-09-16

Last Posted Date: 2013-03-25

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 37

Registration Number: NCT00182702

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Docetaxel
Biological: PANVAC-V
Biological: PANVAC-F
Biological: Sargramostim

First Posted Date: 2005-09-15

Last Posted Date: 2014-07-15

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 48

Registration Number: NCT00179309

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Adrenal Function in Critical Illness

Completed

Conditions: Adrenal Insufficiency

First Posted Date: 2005-09-12

Last Posted Date: 2025-06-26

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 225

Registration Number: NCT00156767

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Obesity Assessment and Education Through the Internet

Phase 2

Completed

Conditions: Obesity

First Posted Date: 2005-09-08

Last Posted Date: 2010-01-13

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 100

Registration Number: NCT00149682

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Consequence of Lifetime Isolated Growth Hormone Deficiency

Not Applicable

Completed

Conditions: Growth Hormone Deficiency

First Posted Date: 2005-09-08

Last Posted Date: 2010-06-15

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 400

Registration Number: NCT00149708

Locations: 🇧🇷
Federal University of Sergipe, Aracaju, Sergipe, Brazil

Breaking Down Barriers to Diabetes Self-Care

Not Applicable

Completed

Conditions: Type 2 Diabetes
Type 1 Diabetes

Interventions: Behavioral: Breaking Down Barriers

First Posted Date: 2005-09-02

Last Posted Date: 2010-03-02

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 222

Registration Number: NCT00142922

Locations: 🇺🇸
Joslin Diabetes Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy